These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31168596)

  • 1. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
    Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
    Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report.
    Isaka M; Kondo H; Maniwa T; Takahashi S; Ohde Y
    J Thorac Oncol; 2016 Jul; 11(7):1176-80. PubMed ID: 27058910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer.
    Rusch VW; Crowley J; Giroux DJ; Goldstraw P; Im JG; Tsuboi M; Tsuchiya R; Vansteenkiste J; ; ; ;
    J Thorac Oncol; 2007 Jul; 2(7):603-12. PubMed ID: 17607115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the Prognostic Impact between Single-zone and Multi-zone N2 Node Metastasis in Patients with Station-based Multiple N2 Non-Small Cell Lung Cancer.
    Kim SA; Lee GD; Choi SH; Kim HR; Kim YH; Kim DK; Park SI; Yun JK
    Cancer Res Treat; 2024 Jul; ():. PubMed ID: 39054625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
    Chen W; Zhang C; Wang G; Yu Z; Liu H
    Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
    Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
    Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
    Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
    J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
    Lee JG; Lee CY; Bae MK; Park IK; Kim DJ; Kim KD; Chung KY
    J Thorac Oncol; 2008 Dec; 3(12):1421-6. PubMed ID: 19057267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.
    Park BJ; Kim TH; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Cho JH
    J Thorac Oncol; 2019 Nov; 14(11):1962-1969. PubMed ID: 31442497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of the number of involved lymph node stations in patients with completely resected non-small cell lung cancer: a proposal for future revisions of the N classification.
    Kojima H; Terada Y; Yasuura Y; Konno H; Mizuno T; Isaka M; Funai K; Ohde Y
    Gen Thorac Cardiovasc Surg; 2020 Nov; 68(11):1298-1304. PubMed ID: 32449108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.